𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Danazol for paroxysmal nocturnal hemoglobinuria

✍ Scribed by Harrington, William J.; Kolodny, Luciano; Horstman, Lawrence L.; Jy, Wenche; Ahn, Yeon S.


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
45 KB
Volume
54
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal stem-cell disorder in which blood cells lack complement inhibiting membrane proteins, and become susceptible to complement-mediated injury, leading to chronic intravascular hemolysis and pancytopenia. Glucocorticoids have been a mainstay of therapy. For patients refractory to glucocorticoids and requiring blood transfusions, an alternative therapy is needed. We studied danazol therapy in 5 patients refractory to other treatments. Four of the 5 benefited, showing rise in hematocrit and eventual cessation of transfusion requirements. Remissions lasted Υ†2 years in 3 and 10 years in 1 patient. Danazol was well-tolerated without serious side effects. Danazol appears to be a good alternative treatment in PNH.


πŸ“œ SIMILAR VOLUMES


Monitoring of CD59 expression in paroxys
✍ Yoshio Katayama; Y. Hiramatsu; K. Kohriyama πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

## Abstract We describe a 52‐year‐old man with paroxysmal nocturnal hemoglobinuria (PNH) and a moderate transfusion requirement. Prior to and during sequential therapy with androgen (metenolone), glucocorticoid, and danazol, we evaluated CD59‐negative expression (PNH clone) in red blood cells, neut

Paroxysmal nocturnal hemoglobinuria term
✍ David E. Cowall; Dominick N. Pasquale; Paul Dekker πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 591 KB

A case of a patient who developed erythroleukemia 3 years into the course of paroxysmal nocturnal hemoglobinuria (PNH) is presented. A case of erythroleukemia with a positive sucrose lysis test has been reported, but our case appears to be the first with a long clinical course of PNH evolving into e